Is Prime Medicine, Inc. overvalued?

Prime Medicine, Inc. (PRME) — key valuation metrics and fundamentals.

No verdict

Price

$3.09

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$558.1M

Dividend yield

32.1%

Return on equity

-188.3%

Sector

Healthcare

Fair value compares PRME's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks